Hoffmann & Partner AG
  • Home
  • Services
    • M&A
    • CFO-Services
  • Team
  • Network
    • Strategic partners
    • Memberships
  • Transactions
  • News
  • Contact
  • EN
    • DE
    • EN
Select Page
Hoffmann & Partner advised Melisana AG in the sale of its brand BIOKOSMA to ebi-pharm ag.

Hoffmann & Partner advised Melisana AG in the sale of its brand BIOKOSMA to ebi-pharm ag.

by H0Adm-01 | Jun 2, 2023 | H&P News, M&A

As a pioneer of Swiss natural cosmetics, BIOKOSMA stands for contemporary care products with selected organic plant extracts since 1935. For strategic reasons, Melisana concentrates on the OTC sector in the future. The fact that the BIOKOSMA brand can be transferred...
Hoffmann & Partner advised Herbonis AG shareholders. Herbonis was sold to Innovad.

Hoffmann & Partner advised Herbonis AG shareholders. Herbonis was sold to Innovad.

by H0Adm-01 | Apr 28, 2023 | H&P News, M&A

Innovad, a portfolio company of IK Partners and a leading provider of animal nutrition and health solutions, has acquired Switzerland based Herbonis AG. Herbonis AG provides a plant-based source of the metabolic active form of Vitamin D, a unique and highly technical...
Hoffmann & Partner expands its service offering and wins a first mandate with Kuros Biosciences

Hoffmann & Partner expands its service offering and wins a first mandate with Kuros Biosciences

by H0Adm-01 | Mar 1, 2023 | CFO-Services, Corporate Finance, M&A, Tax

With the most recent additions to our partnership and board, Hoffmann & Partner has extended their offering to include executive CFO services for listed clients including clients pursuing a listing to an international stock exchange. Further the company now...
Changes in the national tax law destroy one of the biggest advantages for start-ups

Changes in the national tax law destroy one of the biggest advantages for start-ups

by H0Adm-01 | Jan 30, 2023 | CFO-Services, Corporate Finance, M&A, Tax

Employee Stock Ownership Plans (ESOPs) in Switzerland Employee options were an attractive financial instrument before the tax law was changed per 01.01.2021. Prior to the changes employees could exercise their options when the fair value of share prices was still low...
Hoffmann & Partner M&A Insights: Allocation of the total equity value of a company to different share classes

Hoffmann & Partner M&A Insights: Allocation of the total equity value of a company to different share classes

by H0Adm-01 | Oct 28, 2022 | Corporate Finance, M&A

Deriving the adequate values per preferred and common share is not straightforward. Dividing the total equity value or agreed company pre-money valuation in a financing transaction by the total amount of existing shares to receive the issue price is not correct if...
The use of preferred rights in the life sciences industry in Switzerland

The use of preferred rights in the life sciences industry in Switzerland

by H0Adm-01 | Oct 24, 2022 | Corporate Finance, M&A

In our last M&A newsletter (The meaning of preferential rights embedded in preferred shares and empirical evidence in Switzerland) we introduced the nature and economic meaning of different preferential rights embedded in preferred shares.In addition, we have...
« Older Entries

Kategorie:

Design and implementation by BrandSystem GmbH.
  • Follow
  • Follow
Design and implementation by BrandSystem GmbH.